Skip to main content

Table 5 Tracking of DRB in the face of PTX, a concurrent drug in bulk and dosage form

From: The first facile optical density-dependent approach for the analysis of doxorubicin, an oncogenic agent accompanied with the co-prescribed drug; paclitaxel

matrix

aDRB+ PTX Taken

aDRB found

Rec%b

Er%b

SDb

Bulk powder

10.0 + 5

9.74

97.40

2.592

2.11

15.0 + 5

14.79

98.60

-1.399

0.879

20.0 + 5

19.76

98.82

1.172

1.065

 

25.0 + 5

24.58

98.348

-1.165

0.284

Dosage form

10.0 + 5

9.83

98.39

1.604

0.301

15.0 + 5

15.09

100.57

0.576

1.60

20.0 + 5

19.83

99.19

-0.802

1.73

25.0 + 5

24.5

98.00

1.99

2.128

  1. a Concentration (µg mL− 1)
  2. b Mean value of three determinations, Er is the relative error and SD standard deviation
Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us